戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -regulated genes, including Siglec-1 (CD169, sialoadhesin).
2 ntarity of scaffold structure and binding to sialoadhesin.
3                                              Sialoadhesin, a macrophage restricted lectin that binds
4 structures were differentially recognized by sialoadhesin, a mammalian macrophage sialic acid binding
5  carbohydrate binding specificities of three sialoadhesins, a subgroup of I-type lectins (immunoglobu
6  cell surface ligands for the I-type lectins sialoadhesin and CD22.
7           Modulating the interaction between sialoadhesin and its sialic acid ligands has important i
8                                Expression of sialoadhesin and Siglec-F ligands increased, and that of
9                   Given similarities between sialoadhesin and the unidentified macrophage lectin in o
10 e selectins), I-type lectins (e.g., CD22 and sialoadhesin), and a complement regulatory protein (the
11 and 7-deoxysialic acid derivatives supported sialoadhesin binding at near control levels (the other d
12               These data are consistent with sialoadhesin binding to one face of the sialic acid moie
13                                              Sialoadhesin (but not CD22) binding is selectively enhan
14                                              Sialoadhesin (CD169) facilitates T-cell priming when ove
15                           We determined that sialoadhesin (CD169; Siglec-1) is required for the captu
16                                    Siglec-1 (sialoadhesin, CD169) is a surface receptor on human cell
17 dependent viral entry into AMs used ACE2 and Sialoadhesin/CD169, whereas IM entry used DC-SIGN/CD209.
18                        Previous studies with sialoadhesin, CD22 and CD33 have shown that siglec glyco
19 ion to the previously characterized siglecs, sialoadhesin, CD22, CD33 and myelin-associated glycoprot
20 rs ago, only four Siglecs were known, namely sialoadhesin, CD22, myelin-associated glycoprotein and C
21 lectin in our model, we hypothesized porcine sialoadhesin contributed to recognition of human erythro
22  lectins myelin-associated glycoprotein, and sialoadhesin did not disrupt their ability to mediate si
23 Fc, and another sialic acid binding protein, sialoadhesin, each bind to neurons in a sialic acid- dep
24                                 In contrast, sialoadhesin had less exacting specificity, binding to g
25 ing overlapped that of the macrophage marker sialoadhesin in frozen sections and coincided with that
26 we show that receptor sialylation of soluble sialoadhesin inhibits its binding to Jurkat cell ligands
27 ese data support the hypothesis that porcine sialoadhesin is a xenogeneic receptor that mediates porc
28                                        Since sialoadhesin is expressed on some macrophages in vivo, w
29                                   Thus, some sialoadhesin ligands are masked by 9-O-acetylation, pres
30 -deficient or B- and T-deficient mice lacked sialoadhesin+ marginal zone macrophages and lacked MAdCA
31 a > GT1b, GD1a >> GM1 (nonbinding)), whereas sialoadhesin-mediated adhesion was comparable with alpha
32 in vivo macrophage sialylconjugates enhances sialoadhesin-mediated lectin activity.
33 nhibited approximately 90% by an antiporcine sialoadhesin monoclonal antibody and by human erythrocyt
34  (pSn CHO) bound human erythrocytes, while a sialoadhesin mutant cell line did not.
35                                   The neural sialoadhesins, myelin-associated glycoprotein (MAG) and
36                        Monocytes overexpress sialoadhesin nonspecifically during ITx rejection and sy
37 Ac) on the surface of human erythrocytes and sialoadhesin on the surface of the porcine Kupffer cells
38 Surface expression of SIGLEC1, also known as sialoadhesin or CD169, is considered a primary determina
39 able transgenic cell line expressing porcine sialoadhesin (pSn CHO) bound human erythrocytes, while a
40 2, CD33, myelin-associated glycoprotein, and sialoadhesin) show that OB-BP1, OB-BP2/Siglec-5, and CD3
41 ition of interferon-inducible 44 (IFI44) and sialoadhesin (Siglec-1) to COMP and TSP-1 in multiple re
42   First, we report that binding of siglec-1 (sialoadhesin), siglec-3 (CD33), siglec-4a (myelin-associ
43                                              Sialoadhesin (Sn) is a macrophage (Mphi)-restricted rece
44                                              Sialoadhesin (Sn) is a sialic acid-binding Ig-like lecti
45                            CD169 is known as sialoadhesin (Sn), a macrophage-specific adhesion and en
46 he identification of two of these ligands as sialoadhesin (Sn), an Mo-specific membrane molecule, and
47 to Ig domains from another Ig family member, sialoadhesin (Sn), which also binds to sialic acid in th
48                   Several siglecs, including sialoadhesin (Sn, siglec-1) and siglec-5, bind to NeuAca
49                                              Sialoadhesin (Sn, Siglec-1, CD169) is a member of the si
50                                              Sialoadhesin (Sn, Siglec-1, CD169), a sialic acid-bindin
51 tures of the N-terminal domain of the Siglec sialoadhesin (SnD1) in complex with various sialic acid
52                              Human siglec-1 (sialoadhesin) strongly prefers Neu5Ac over Neu5Gc.
53                     Binding of MAG, SMP, and sialoadhesin was abrogated by chemical modification of e
54                                Expression of sialoadhesin was confirmed by immunofluorescence in porc
55             The binding of the sialosides to sialoadhesin was evaluated by an enzyme-linked immunosor
56 MAG), Schwann cell myelin protein (SMP), and sialoadhesin, were compared by measuring siglec-mediated
57 he macrophage-specific cell surface receptor sialoadhesin, which is a member of the newly recognized